Overview

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-7548 in patients with cancer.

Phase:

Phase 1

Details

Lead Sponsor:

Life Molecular Imaging SA
Piramal Imaging SA

Treatments:

Bombesin
Gastrin-Releasing Peptide